Back
Pacific Biosciences of California Vs. Navidea Biopharmaceuticals Industry Stock Comparison
Sell
27
PACB
Pacific Biosciences of California
Last Price:
3.72
Seasonality Move:
-1.44%
Sell
14
NAVB
Navidea Biopharmaceuticals
Last Price:
0.04
Seasonality Move:
4.74%
Sell
27
Pacific Biosciences of California (PACB)
is a Sell
Is Pacific Biosciences of California a Buy, Sell or Hold?
- The current Pacific Biosciences of California [PACB] share price is $3.72. The Score for PACB is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- PACB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
14
Navidea Biopharmaceuticals (NAVB)
is a Sell
Is Navidea Biopharmaceuticals a Buy, Sell or Hold?
- The current Navidea Biopharmaceuticals [NAVB] share price is $0.04. The Score for NAVB is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- NAVB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
PACB Stock Price Chart
What is Pacific Biosciences of California's stock price today?
-
The Pacific Biosciences of California share price today is $3.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PACB is experiencing slight buying pressure.
NAVB Stock Price Chart
What is Navidea Biopharmaceuticals's stock price today?
-
The Navidea Biopharmaceuticals share price today is $0.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NAVB is experiencing buying pressure, which is a positive indicator for future bullish movement.
PACB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.57 | Sell |
Relative Strength Index (14 RSI): | 34.71 | Sell |
Chaikin Money Flow: | 2309181 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.7 - 5.08) | Sell |
Bollinger Bands (100): | (5.03 - 8.81) | Sell |
NAVB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 44.45 | Sell |
Chaikin Money Flow: | -56053 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.04 - 0.04) | Sell |
Bollinger Bands (100): | (0.04 - 0.06) | Sell |
PACB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.69 | Buy |
20-day SMA: | 4.15 | Sell |
50-day SMA: | 5.45 | Sell |
200-day SMA: | 8.86 | Sell |
8-day EMA: | 3.74 | Sell |
20-day EMA: | 4.19 | Sell |
50-day EMA: | 5.32 | Sell |
200-day EMA: | 7.88 | Sell |
NAVB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.04 | Sell |
20-day SMA: | 0.04 | Sell |
50-day SMA: | 0.04 | Sell |
200-day SMA: | 0.07 | Sell |
8-day EMA: | 0.04 | Sell |
20-day EMA: | 0.04 | Sell |
50-day EMA: | 0.04 | Sell |
200-day EMA: | 0.09 | Sell |
Pacific Biosciences of California Earnings Growth & PACB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.19 per share.
Navidea Biopharmaceuticals Earnings Growth & NAVB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Pacific Biosciences of California Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Navidea Biopharmaceuticals Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |